NS
ELDN icon

NBC Securities’s Eledon Pharmaceuticals ELDN Stock Holding History

NBC Securities’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.8K Buy
+3,000
New +$10.9K ﹤0.01% 1823

Other funds holding ELDN

TCM
Triumph Capital Management Denver, Colorado $552M AUM 20.75% 1-Year Est. Return
PAM
Prodigy Asset Management Omaha, Nebraska $332M AUM 10.57% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
HFS
Howard Financial Services Dallas, Texas $1B AUM 20.02% 1-Year Est. Return
RZH
Relyea Zuckerberg Hanson Stamford, Connecticut $1.2B AUM 28.45% 1-Year Est. Return
RWP
Revolve Wealth Partners Hackensack, New Jersey $965M AUM 22.88% 1-Year Est. Return
GWM
GK Wealth Management Reno, Nevada $190M AUM 66.42% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
SRPTWM
Split Rock Private Trading & Wealth Management Cloquet, Minnesota $146M AUM

NBC Securities's ELDN Position: Q2 2026 in Review

NBC Securities opened a new position in Eledon Pharmaceuticals (ELDN) in Q2 2026: 3,000 shares worth $11.8K. The stake represents ﹤0.01% of the portfolio and ranks #1823 among its holdings.

21 funds tracked by Wall St. Rank hold ELDN as of Q2 2026.

  • NBC Securities held 3,000 shares of Eledon Pharmaceuticals worth $11.8K as of Q2 2026.
  • Eledon Pharmaceuticals was a new NBC Securities position in Q2 2026.
  • Eledon Pharmaceuticals made up ﹤0.01% of NBC Securities's portfolio in Q2 2026, its #1823 holding.
  • 21 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q2 2026.

Based on NBC Securities's 13F filing for Q2 2026, filed 21 Jul 2026.